Bioventus Inc.
BVS · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3 | $9 | -$3 | -$0 |
| Dep. & Amort. | $11 | $12 | $12 | $12 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $0 | $4 | $2 | $2 |
| Change in WC | $11 | $0 | -$31 | -$2 |
| Other Non-Cash | $5 | $0 | $1 | $4 |
| Operating Cash Flow | $30 | $26 | -$19 | $19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $25 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1 | $0 | $0 |
| Investing Cash Flow | -$0 | -$1 | -$1 | $24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$20 | -$5 | $10 | -$48 |
| Stock Issued | $0 | $1 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$11 | -$9 | $4 |
| Financing Cash Flow | -$20 | -$15 | $1 | -$43 |
| Forex Effect | -$0 | $0 | $0 | -$2 |
| Net Chg. in Cash | $9 | $10 | -$19 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33 | $23 | $42 | $43 |
| End Cash | $42 | $33 | $23 | $42 |
| Free Cash Flow | $30 | $25 | -$20 | $19 |